Evidence map›Paper›PMID 42181555›Full record

ArticleMayo Clinic proceedings. Digital health2026

Arkangel AI, OpenEvidence, ChatGPT, Medisearch: Are They Objectively up to Medical Standards? A Real-Life Assessment of LLM Chatbots in Health Care.

Natalia Castaño-Villegas, María Camila Villa, Katherine Monsalve Barrientos, Isabella Llano, Laura Velásquez, José Zea

Abstract read
In one paragraph

Article in Mayo Clinic proceedings. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natalia Castaño-VillegasArkangel AI, Bogotá, Colombia.
María Camila VillaArkangel AI, Bogotá, Colombia.
Katherine Monsalve BarrientosArkangel AI, Bogotá, Colombia.
Isabella LlanoArkangel AI, Bogotá, Colombia.
Laura VelásquezArkangel AI, Bogotá, Colombia.
José ZeaArkangel AI, Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To compare the performance of 4 large language model chatbots in response time and quality of clinical answers, evaluated by specialists using predefined validity criteria. Participants and Methods: Between June 1 and September 20, 2025, four clinical vignettes (orthopedics, pediatrics, gynecology, and psychiatry) were developed by independent experts and answered by 4 conversational agents: Arkangel AI, OpenEvidence, ChatGPT, and Medisearch. Each vignette included 4 questions (diagnosis, clinical management, research, and general knowledge). Responses were independently evaluated by external clinicians using an 8-criterion Likert scale assessing correctness, consensus agreement, absence of bias, adherence to standards of care, timeliness, patient safety, authenticity of cited references, and contextual appropriateness. Response times were summarized using medians and interquartile ranges. Results: A total of 128 question-answer pairs (1024 evaluations) were analyzed. Overall satisfaction ranged from 71.1% (727) to 93% (952) across agents, with statistically significant differences (Kruskal-Wallis Conclusion: Large language model chatbots showed substantial variability across validity dimensions when assessed using expert clinical judgment, supporting the need for standardized, multidimensional evaluation frameworks.

Identifiers

PMID42181555
PMCPMC13195604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.